Keely M. Hack
Expertise in
25
conditions

Dr. Keely M. Hack

Hematology | Oncology
Sanford Worthington Cancer Center
1018 Sixth Ave., 
Worthington, MN 
Accepting New Patients
Offers Telehealth
Expertise in
25
conditions
Sanford Worthington Cancer Center
1018 Sixth Ave., 
Worthington, MN 

Overview

Dr. Keely Hack specializes in medical oncology and blood disorders. Dr. Hack is also a member of the Edith Sanford Breast Center Physician Leadership Council, a physician-led, multidisciplinary group designed to help direct efforts for optimal breast health care. Speaks: English.

Dr. Hack is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Gastrostomy.

Dr. Hack is board certified in American Board Of Internal Medicine: Internal MedicineAmerican Board Of Internal Medicine: Medical OncologyAmerican Board Of Internal Medicine: Hematology. She is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 2 clinical trials. Dr. Hack is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in NE

Board Certifications

American Board Of Internal Medicine: Internal MedicineAmerican Board Of Internal Medicine: Medical OncologyAmerican Board Of Internal Medicine: Hematology

Fellowships

University of Nebraska Medical Center, Hematology/Oncology

Hospital Affiliations

Murray County Memorial Hospital
Sanford Worthington Medical Center
Sanford Vermillion Medical Center
Winner Regional Healthcare Center - Cah
Sanford Usd Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 10 Less Insurance Carriers -

Locations

Sanford Worthington Cancer Center
1018 Sixth Ave., Worthington, MN 56187
Other Locations
Sanford Cancer Center
1309 W. 17th St., Sioux Falls, SD 57104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Carboplatin, Cetuximab
Study Phase: Phase 2
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug, Radiation, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Cetuximab
Study Phase: Phase 2
View 1 Less Clinical Trial

3 Total Publications

Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: December 01, 2023
Similar Doctors
Expertise in
52
conditions
Dr. Vinod Parameswaran
Hematology | Oncology
Expertise in
52
conditions
Dr. Vinod Parameswaran
Hematology | Oncology
Referral may be required

Avera Medical Group Hematology

1000 E 23rd St Ste 200, 
Sioux Falls, SD 
 (57.4 miles away)
605-322-3035
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vinod Parameswaran is a Hematologist and an Oncologist practicing medicine in Sioux Falls, South Dakota. Dr. Parameswaran is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, Thrombocytopenia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Parameswaran is currently accepting new patients.

Expertise in
68
conditions
Dr. Jonathan S. Bleeker
Hematology | Oncology
Expertise in
68
conditions
Dr. Jonathan S. Bleeker
Hematology | Oncology
Referral may be required

Sanford Luverne Clinic

1601 Sioux Valley Drive, 
Luverne, MN 
 (30.8 miles away)
507-283-4476
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Jonathan Bleeker specializes in oncology and hematology. He focuses on bringing the latest in cancer research to his patients. Speaks: English. Dr. Bleeker is highly rated in 68 conditions, according to our data. His clinical expertise encompasses Ataxia-Pancytopenia Syndrome, Fanconi Anemia, Shwachman-Diamond Syndrome, Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Bleeker is board certified in American Board Of Internal Medicine: Medical OncologyAmerican Board Of Internal Medicine: HematologyAmerican Board Of Internal Medicine: Internal Medicine. Dr. Bleeker is currently accepting new patients.

Expertise in
70
conditions
Dr. Miroslaw A. Mazurczak
Oncology | Hematology
Expertise in
70
conditions
Dr. Miroslaw A. Mazurczak
Oncology | Hematology
Referral may be required

Sanford Worthington Cancer Center

1018 Sixth Ave., 
Worthington, MN 
 (0.1 miles away)
507-372-3800
Languages Spoken:
English, Polish, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Speaks: English, Polish. Dr. Mazurczak is highly rated in 70 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Mazurczak is board certified in American Board Of Internal Medicine: HematologyAmerican Board Of Internal Medicine: Oncology. Dr. Mazurczak is currently accepting new patients.

Frequently Asked Questions about Dr. Keely M. Hack

How do I make an appointment with Dr. Keely M. Hack?

You can book an appointment with Dr. Keely M. Hack by calling their office at 507-372-3800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Keely M. Hack a top-rated expert for Angiosarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Keely M. Hack is classified as an Distinguished expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Keely M. Hack specialize in?

While Dr. Keely M. Hack is a Hematology, they have specific expertise in Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Keely M. Hack participate in research or clinical trials?

Yes. Dr. Keely M. Hack has published 3 articles and abstracts on conditions like Angiosarcoma. You can view a list of Dr. Keely M. Hack's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Keely M. Hack accept my insurance?

Dr. Keely M. Hack accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 507-372-3800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hack's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 97 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile